Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC today announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for a generic version of Lodosyn®* (Carbidopa Tablets 25mg). Edenbridge will begin shipping its Carbidopa Tablets 25mg shortly. Carbidopa tablets are indicated for use with carbidopa-levodopa or with levodopa in the treatment of the symptoms of Parkinson’s Disease. For more information please contact the Company directly at info@dexcelpharmausa.com..
Carbidopa Tablets Launch
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.